Efficacy and Safety of Bevacizumab Combined with Chemotherapy as Second-line or Later-line Treatment in Advanced Nonsquamous Non-small Cell Lung Cancer

Efficacy and Safety of Bevacizumab Combined with Chemotherapy as Second-line or Later-line Treatment in Advanced Nonsquamous Non-small Cell Lung Cancer

Background and objective Bevacizumab combined with platinum-based chemotherapy has been recommended as the first-line agent in advanced nonsquamous non-small cell lung cancer (NSCLC) without driven gene, but this regimen is not common in the second-line or later-line treatment of non-squamous NSCLC....

Full description

Bibliographic Details
Main Authors: Xuanxuan ZHENG, Huijuan WANG, Guowei ZHANG, Xiangtao YAN, Zhiyong MA
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2018-07-01
Series:Chinese Journal of Lung Cancer
Subjects:
Bevacizumab
Lung neoplasms
Chemotherapy
Efficacy
Brain metastases
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2018.07.02

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2018.07.02

Similar Items